{"id":"W2590936583","doi":"10.1200/jco.2016.34.2_suppl.340","title":"Metformin (Met): A cost-effective adjunct therapy with enzalutamide (Enza) for metastatic castrate-resistant prostate cancer (mCRPC)?","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Prostate cancer; Quality-adjusted life year; Enzalutamide; Cancer; Actuarial science; Cost effectiveness; Internal medicine; Risk analysis (engineering); Economics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002440442,0.0005133951,0.0008707913,0.000695776,0.0002013274,0.0009396363,0.0006047979,0.001021423,0.003506117],"category_scores_gemma":[0.006516708,0.0003298818,0.001533172,0.0003758393,0.0003735352,0.0008639749,0.0005570977,0.0008745485,0.000144226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0019446,"about_ca_system_score_gemma":0.002283872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003012701,"about_ca_topic_score_gemma":0.005511351,"domain_scores_codex":[0.9987148,0.0009011924,0.00005643147,0.0001151119,0.0001243501,0.00008821243],"domain_scores_gemma":[0.997748,0.001690429,0.0003571297,0.00002560777,0.00005508263,0.0001237872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0203397,0.001907456,0.02780349,0.004139086,0.002159551,0.000726996,0.0001708509,0.6856354,0.003677695,0.01731501,0.003257143,0.2328676],"study_design_scores_gemma":[0.003886949,0.01310216,0.01330484,0.002511039,0.004708219,0.0007750942,0.0002873083,0.9233534,0.002637481,0.02373816,0.01155384,0.0001414102],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8874887,0.02174052,0.05506659,0.009971843,0.000225375,0.001888417,0.002177145,0.0001863225,0.0212551],"genre_scores_gemma":[0.9889313,0.001983054,0.007883769,0.0003767598,0.00002979706,0.0001602248,0.0001586909,0.000004461448,0.0004718617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003506117,"threshold_uncertainty_score":0.01410913,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1878538938582237,"score_gpt":0.5275029001028327,"score_spread":0.339649006244609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}